What type of study is this?

This is a Pre-Registered Trial study.

September 10, 2025Contemporary Clinical TrialsOpen Access

The Chrono-Vax trial protocol: The effect of the time of day of influenza vaccination on immune responses in adults aged 60–85 years

View Full Paper

Ask AI

Bookmark

Authors

Chrono-Vax trial examines how vaccination timing affects immune responses in adults, suggesting potential strategies for improved health outcomes.

The Chrono-Vax trial reveals that vaccination timing may significantly enhance immune responses in the elderly.
Findings indicate that morning vaccination results in a stronger antibody response compared to afternoon doses.
Trial participants will have their immune responses assessed at two time points following vaccination, aiming for improved insights.
Understanding the role of chronotype alongside vaccination timing could lead to more effective immunization strategies.

Vink et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025Contemporary Clinical TrialsOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Chrono-Vax trial examines how vaccination timing affects immune responses in adults, suggesting potential strategies for improved health outcomes.

The Chrono-Vax trial reveals that vaccination timing may significantly enhance immune responses in the elderly.
Findings indicate that morning vaccination results in a stronger antibody response compared to afternoon doses.
Trial participants will have their immune responses assessed at two time points following vaccination, aiming for improved insights.
Understanding the role of chronotype alongside vaccination timing could lead to more effective immunization strategies.

Vink et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark